We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.28T Turnover 24.66%
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+35.7%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$1.28T
AUM Growth
+$391B
Cap. Flow
+$19.1B
Cap. Flow %
1.49%
Top 10 Hldgs %
26.66%
Holding
15,023
New
1,956
Increased
5,793
Reduced
5,445
Closed
1,748
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
5.1 years
Top 20 Avg Time Held Equity + Options
5.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.8 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.8%
2 Technology 2.93%
3 Communication Services 0.62%
4 Consumer Discretionary 0.61%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLND icon
12951
Greenland Energy
GLND
$92.7M
$31.2K ﹤0.01%
+14,163
New +$57.1K
2026 Q2
0 quarters
CTRM icon
12952
CALL
Castor Maritime
CTRM
$12.7M
$31.1K ﹤0.01%
14,900
-8,800
-37% -$17.5K
2025 Q4
2 quarters
INVE icon
12953
PUT
INVE Technologies
INVE
$64.5M
$31K ﹤0.01%
+12,300
New +$49.4K
2026 Q2
0 quarters
HAIN icon
12954
CALL
Hain Celestial
HAIN
$12.8M
$30.9K ﹤0.01%
+55,200
New +$41K
2026 Q2
0 quarters
LPSN icon
12955
PUT
DELISTED
LivePerson
LPSN
$30.8K ﹤0.01%
16,200
-110,600
-87% -$266K
2019 Q3
27 quarters
MIST icon
12956
PUT
Milestone Pharmaceuticals
MIST
$64.7M
$30.3K ﹤0.01%
22,600
-87,500
-79% -$140K
2024 Q4
6 quarters
SPRO icon
12957
CALL
Spero Therapeutics
SPRO
$58.3M
$30.3K ﹤0.01%
+13,700
New +$35.8K
2026 Q2
0 quarters
ATOS icon
12958
Atossa Therapeutics
ATOS
$19.6M
$30.1K ﹤0.01%
+15,574
New +$71K
2026 Q2
0 quarters
AIV icon
12959
PUT
Aimco
AIV
$212M
$30K ﹤0.01%
10,100
– –
2025 Q2
4 quarters
OPNW icon
12960
OpenWorld
OPNW
$7.96M
$29.9K ﹤0.01%
+4,878
New +$35.9K
2026 Q2
0 quarters
HLLY icon
12961
Holley
HLLY
$302M
$29.9K ﹤0.01%
11,732
-17,731
-60% -$50.3K
2026 Q1
1 quarter
RMCF icon
12962
Rocky Mountain Chocolate Factory
RMCF
$7.01M
$29.9K ﹤0.01%
+33,607
New +$67.7K
2026 Q2
0 quarters
SYPR icon
12963
PUT
Sypris Solutions
SYPR
$24.4M
$29.9K ﹤0.01%
+12,300
New +$38.2K
2026 Q2
0 quarters
GRCE icon
12964
CALL
Grace Therapeutics
GRCE
$38.1M
$29.5K ﹤0.01%
13,000
-37,600
-74% -$104K
2026 Q1
1 quarter
SLNH icon
12965
Soluna Holdings
SLNH
$122M
$29.4K ﹤0.01%
+21,743
New +$31.4K
2026 Q2
0 quarters
DAVA icon
12966
PUT
Endava
DAVA
$77.2M
$29.1K ﹤0.01%
+10,300
New +$38K
2026 Q2
0 quarters
RPGL icon
12967
Republic Power Group
RPGL
$8.88M
$29K ﹤0.01%
+920
New +$289K
2026 Q2
0 quarters
TXMD icon
12968
CALL
TherapeuticsMD
TXMD
$21.6M
$29K ﹤0.01%
+13,100
New +$27.1K
2026 Q2
0 quarters
STEX icon
12969
PUT
Streamex
STEX
$38M
$28.9K ﹤0.01%
34,000
+7,800
+30% +$8.07K
2025 Q3
3 quarters
SMXT icon
12970
Solarmax Technology
SMXT
$19.5M
$28.9K ﹤0.01%
+6,894
New +$43.8K
2026 Q2
0 quarters
ZJK icon
12971
ZJK Industrial
ZJK
$74.6M
$28.9K ﹤0.01%
+14,498
New +$35.7K
2026 Q2
0 quarters
AACG icon
12972
ATA Creativity
AACG
$33.6M
$28.8K ﹤0.01%
27,955
+7,373
+36% +$8.03K
2025 Q2
4 quarters
ORIO icon
12973
Orion Digital
ORIO
$25M
$28.8K ﹤0.01%
33,869
+23,635
+231% +$22.8K
2025 Q4
2 quarters
VIDA icon
12974
VIDA Global
VIDA
$11M
$28.7K ﹤0.01%
+10,267
New +$39.9K
2026 Q2
0 quarters
AXINR icon
12975
Axiom Intelligence Acquisition Corp 1 Right
AXINR
$28.7K ﹤0.01%
+77,285
New +$25.9K
2026 Q2
0 quarters

Similar funds

Jeff Yass's Q2 2026 Portfolio in Review

As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q2 2026 filing shows 1,956 new, 5,793 increased, 5,445 reduced and 1,748 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M. The largest sale was Invesco QQQ Trust, an estimated $1.78B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
  • Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
  • Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
  • Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
  • Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.